We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Reliance Gen. | GMX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.55 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.55 | 0.55 |
| Top Posts |
|---|
Posted at 04/10/2005 09:13 by wiganer GMX left today. Sinking ship, or multi-bagger? |
Posted at 27/4/2004 09:50 by amarone My Dear Handycam, these guys don't sound like people who stand in the bookies smoking a cigarette all day. GMX have a very good network in the Far East and it looks like TH Group must have undertook some form of due diligence BEFORE making this £360k investment. IMHO etc, AMARONE. KUALA LUMPUR (AFX-ASIA) - TH Group Bhd via its unit THG Capital Sdn Bhd has invested some 3.8 mln rgt to raise its investments in two companies, South Korean-based C-Solution Inc Korea and British-based GemeMedix PLC. Both subscriptions were funded by internally generated funds, TH Group said. In a statement, the company said THG Capital has subscribed to eight redeemable convertible bonds worth 1.33 mln rgt in C-Solution. The group had previously subscribed to 232,500 shares in C-Solution for 10.07 mln rgt or 19.9 pct of post equity interest in the company in April last year. C-Solution produces tab ends for beverage makers. THG Capital has also subscribed to 2.43 mln shares of GeneMedix worth 2.45 mln rgt. In Nov 29, 2000 TH Group invested 15.3 mln rgt for 3.11 mln shares via another subsidiary Technology Asia Ventures Sdn Bhd and for 3.0 mln shares via THG Capital in July last year. GeneMedix, a biopharmaceutical products company, develops, manufacture and market a range of products for the treatment of chronic diseases such as cancer. (1 usd = 3.8 rgt) afxklumpur@afxasia.c str/lll/mh |
Posted at 26/4/2004 21:16 by handycam My Dear Amarone,I encourage you to believe in the fact that a lot of directors do, actually, tell lies. Goodness knows how they habitually get away with it, but there we are. Remember also that, just like Turbo Genset, this duff company started life on ofex ( and to ofex it should return) with a market cap of £11m, equivalent to c. 3.5 pence in today's share price. Since that listing they have achieved nothing, apart from pee away a shedload of cash in a similar fashion to Scoot and Bright Station. I also recall that the gentleman behind the float trousered a bucketload of money from this and other comapnies before they, too, took a very real caning. You should ask people who paid £2 for this stock and ask them two questions: 1. What on earth made them pick up the phone to part with their cash for GMX? and 2. How do they feel now? I bet none would average down. In fact, if they are moderately intelligent, they would cut and reverse their long position and quadruple their bet on a CFD bear. Yours etc., Steven Ps. The placing was not with institutions, more like with Singaporean punters giving the company one last throw of the dice (and all of whom ought to know better). As British people did woth Eurodis and Mayflower. |
Posted at 15/4/2004 16:20 by amarone handycam - looks like GMX were able to raise £1.9 million via an institutional placing in the Far East. As of today's announcement I am rating them a buy for the following reasons:1. They will have enough cash to see them through the launch of two significant new products 2. They intend to list on the NYSE 3. They are still in partnership talks 4. They now have time to collect the cash owing to them 5. The placing was not at a substantial discount to current share price As always DYOR etc. AMARONE. |
Posted at 04/3/2004 13:54 by nil pd AMARONE: been away from the boards. My view is that conclusion of a deal is imminent. Usually someone gets a sniff of these things from one or two individuals sharing confidential information with their close confidentes. This together with speculation has determined that recent prices were simply far too cheap. The company has stated that it is in discussions and, as I mentioned a few days back, it is incumbent on the company to close this deal quickly to avoid further market uncertainty - and of course to seal a safe future for the business.The deal will have to be satisfactory and therefore will revalue the shares considerably. By exactly how much is impossible to guess at this point but I feel we are looking at adding at least 10p to the price from here. Depends on the deal (cash/shares/both?). If it is not satisfactory, I reiterate my view that major pharma are desperate for pipeline and revenue and have pressure from both common business sense and shareholders to act. There are, IMO, companies waiting to pick up GMX if current discussions fail. If there is any mention of raising funds from shareholders it will be a tactic to close the deal at a higher price and fundraising will not materialise. As an avid pharma watcher my view is it should be good for both GMX and the other side. As you know I have an interest and at a higher price (failed to apply a stop loss). But I see an exciting few days ahead and do not anticipate closing this at a loss. Knowing that you have a keen eye for this sector, I expect none of the above to surprise you. To any reader of this, all the above is IMHO. Please DYOR. |
Posted at 04/3/2004 10:06 by pariah amarone -badly expressed but more or less what I was saying in possibility (a)...there is the possibility of some major good news around the corner -from Malaysia.......perha |
Posted at 03/3/2004 18:49 by amarone pariah - apologies but there is no LOGIC to the rise today. Firstly, the 'news' was a simple RNS which has to be reported due to the fact that Nomura is a book builder and secondly GMX is a high risk/high reward play however, even some of the punters who may have bought Marconi in 2000 would not have classed this as good news and bought in !! The LSE price for GMX is beginning to track the SGX price and not the other way around. GMX finished up 8% last night and LSE MM's followed. Like I said before, GMX is far more involved in the Far East markets due to their connections with the Maylasian Government and SGX, so perhaps the only 'logical' conclusion to today's rise is that they may know more than we do. Lets see what happens on the SGX tonight. Nil Pd - your thoughts please ??IMHO,DYOR etc. AMARONE. |
Posted at 23/2/2004 13:47 by andyprice5569 Hi Nil Pd,'Now I wonder what would happen if Singapore traders bought their shares here (for two thirds of the price) instead of locally. Seems like we will be moving toward parity soon.' What is 'parity'? Firstly, one has to find out what price GMX opened at on the Singapore stock exchange (the first day of trading); find out what the GMX UK share price was that day; find out what the exchange rates (£ and Singapore $) was on the day GMX opened in Singapore; find out what the exchange rate for the £ and Sing $ is today; find out the difference. Currency fluctuations between the £ and the Sing $ will have had an effect on the price of shares in the UK (you think cheap) compared to the price of shares in Singapore (where you think they are dearer). HTH - Regs, Andy |
Posted at 19/2/2004 16:07 by amarone Hi andyprice5569,you see that's exactly why I DONT see the deal as a cash bid, rather a merger. That way GMX get access the other companies assets, resources AND US distribution network all in one hit, not just the cash and in turn their partner gets their hands on the generic (ex.patent) drugs. I would not be suprised if this was a US pharma that will list GMX as a spin-off producing ex.patent drugs. I'll be spending some time cross referencing the drugs GMX are currently finalising with the current patent holder and see if there is any connections (however spurious). It will also give an idea of income revenue stream potential for the GMX products based upon the expiry of the current patent. ps.who do you use as your broker as i am thinking of DJing mine - if it's not too personal |
Posted at 18/2/2004 12:32 by captainspock Looks like the battle is on for the biggest %age gainer on the day.After a big tree-shake for TAN it has overtaken GMX & is now back up 66% on the day. Come on GMX 75% would be wonderful !!!! PS. No ramp intended, just want GMX to be top of the risers today, OK. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
